4//SEC Filing
Rhodes Jennifer J 4
Accession 0001209191-19-038602
CIK 0001328143other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:38 PM ET
Size
5.1 KB
Accession
0001209191-19-038602
Insider Transaction Report
Form 4
Rhodes Jennifer J
General Counsel
Transactions
- Sale
Common Stock
2019-06-20$5.35/sh−940$5,029→ 63,114 total
Footnotes (2)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]Includes 2,442 shares purchased on 5/31/19 through the issuer's employee stock purchase plan.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001568249
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:38 PM ET
- Size
- 5.1 KB